{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:33:03Z","timestamp":1776681183181,"version":"3.51.2"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"project 3TR of the Innovative Medicines Initiative of the European Union","award":["831434"],"award-info":[{"award-number":["831434"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Much is said about precision medicine, but its real significance and potential are far from certain. Several studies in each of the autoimmune diseases have provided important insights into molecular pathways, but the use of molecular studies, particularly those looking into transcriptome pathways, has seldom approached the possibility of using the data for disease stratification and then for prediction, or for diagnosis. Only the type I IFN signature has been considered for therapeutic purposes, particularly in the case of SLE. This review provides an update on precision medicine, on what can be translated into clinical practice and on what single-cell molecular studies contribute to our knowledge of autoimmune diseases, focusing on a few examples. The main message is that we should try to move from precision medicine of established diseases to preventive medicine in order to predict the development of disease.<\/jats:p>","DOI":"10.1093\/rheumatology\/keab448","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T19:11:01Z","timestamp":1621019461000},"page":"3977-3985","source":"Crossref","is-referenced-by-count":20,"title":["Precision medicine in autoimmune diseases: fact or fiction"],"prefix":"10.1093","volume":"60","author":[{"given":"Daniel","family":"Toro-Dom\u00ednguez","sequence":"first","affiliation":[{"name":"Pfizer-University of Granada-Andalusian Regional Government (GENYO), Center for Genomics and Oncological Research, Parque Tecnol\u00f3gico de la Salud, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-4154","authenticated-orcid":false,"given":"Marta E","family":"Alarc\u00f3n-Riquelme","sequence":"additional","affiliation":[{"name":"Pfizer-University of Granada-Andalusian Regional Government (GENYO), Center for Genomics and Oncological Research, Parque Tecnol\u00f3gico de la Salud, Granada, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"2021090119431005300_keab448-B1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamapediatrics.2013.158","article-title":"Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study","volume":"167","author":"Beyerlein","year":"2013","journal-title":"JAMA Pediatr"},{"key":"2021090119431005300_keab448-B2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"2021090119431005300_keab448-B3","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021090119431005300_keab448-B4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"2021090119431005300_keab448-B5","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3389\/fimmu.2019.01880","article-title":"Epigenome-wide comparative study reveals key differences between mixed connective tissue disease and related systemic autoimmune diseases","volume":"10","author":"Carnero-Montoro","year":"2019","journal-title":"Front Immunol"},{"key":"2021090119431005300_keab448-B6","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1136\/annrheumdis-2015-208410","article-title":"IFI44L promoter methylation as a blood biomar ker for systemic lupus erythematosus","volume":"75","author":"Zhao","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021090119431005300_keab448-B7","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021090119431005300_keab448-B8","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/db13-1777","article-title":"A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes","volume":"63","author":"Ferreira","year":"2014","journal-title":"Diabetes"},{"key":"2021090119431005300_keab448-B9","doi-asserted-by":"crossref","first-page":"e122146","DOI":"10.1172\/jci.insight.122146","article-title":"Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes","volume":"3","author":"Vecchio","year":"2018","journal-title":"JCI Insight"},{"key":"2021090119431005300_keab448-B10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2337\/db10-1269","article-title":"An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes","volume":"60","author":"Winkler","year":"2011","journal-title":"Diabetes"},{"key":"2021090119431005300_keab448-B11","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/brain\/awp228","article-title":"A type I interferon signature in monocytes is associated with poor response to interferon-\u03b2 in multiple sclerosis","volume":"132","author":"Comabella","year":"2009","journal-title":"Brain"},{"key":"2021090119431005300_keab448-B12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13075-016-0946-9","article-title":"Physiological evidence for diversification of IFN\u03b1- and IFN\u03b2-mediated response programs in different autoimmune diseases","volume":"18","author":"de Jong","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2021090119431005300_keab448-B13","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/BF02208992","article-title":"Primary biliary cirrhosis induced by interferon-\u03b1 therapy for hepatitis C virus infection","volume":"40","author":"D'Amico","year":"1995","journal-title":"Dig Dis Sci"},{"key":"2021090119431005300_keab448-B14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2018.08.003","article-title":"Interferon alpha: the key trigger of type 1 diabetes","volume":"94","author":"Lombardi","year":"2018","journal-title":"J Autoimmun"},{"key":"2021090119431005300_keab448-B15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/10799900152434321","article-title":"Myasthenia gravis during low-dose IFN-\u03b1 therapy for chronic hepatitis C","volume":"21","author":"Borgia","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"2021090119431005300_keab448-B16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/intimm\/dxg088","article-title":"Spontaneous production of anti-IFN-\u03b1 and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor","volume":"15","author":"Shiono","year":"2003","journal-title":"Int Immunol"},{"key":"2021090119431005300_keab448-B17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrrheum.2018.23","article-title":"Moving towards a molecular taxonomy of autoimmune rheumatic diseases","volume":"14","author":"Barturen","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021090119431005300_keab448-B18","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/art.30458","article-title":"Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus","volume":"63","author":"Ramage","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021090119431005300_keab448-B19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021090119431005300_keab448-B20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/art.41610","article-title":"Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases","volume":"73","author":"Babaei","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2021090119431005300_keab448-B21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0961203316641770","article-title":"Multiparametric detection of autoantibodies in systemic lupus erythematosus","volume":"25","author":"Budde","year":"2016","journal-title":"Lupus"},{"key":"2021090119431005300_keab448-B22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized immunomonitoring uncovers molecular networks that stratify lupus patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"2021090119431005300_keab448-B23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","article-title":"A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus","volume":"29","author":"Chaussabel","year":"2008","journal-title":"Immunity"},{"key":"2021090119431005300_keab448-B24","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.40653","article-title":"Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression","volume":"70","author":"Toro-Dominguez","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2021090119431005300_keab448-B25","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1038\/s41598-019-51616-9","article-title":"Differential treatments based on drug-induced gene expression signatures and longitudinal systemic lupus erythematosus stratification","volume":"9","author":"Toro-Dominguez","year":"2019","journal-title":"Sci Rep"},{"key":"2021090119431005300_keab448-B26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2021090119431005300_keab448-B27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","article-title":"Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients","volume":"26","author":"Qin","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2021090119431005300_keab448-B28","doi-asserted-by":"crossref","first-page":"e22633","DOI":"10.1002\/jcla.22633","article-title":"Neutrophil-to-C3 ratio and neutrophil-to-lymphocyte ratio were associated with disease activity in patients with systemic lupus erythematosus","volume":"33","author":"Yu","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"2021090119431005300_keab448-B29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/0961203318821176","article-title":"Utility of neutrophil-to-lymphocyte ratio plus C-reactive protein for infection in systemic lupus erythematosus","volume":"28","author":"Broca-Garcia","year":"2019","journal-title":"Lupus"},{"key":"2021090119431005300_keab448-B30","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.21873\/anticanres.13381","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic indicator in patients with unresectable gastric cancer","volume":"39","author":"Murakami","year":"2019","journal-title":"Anticancer Res"},{"key":"2021090119431005300_keab448-B31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10147-019-01583-y","article-title":"Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic colorectal cancer surgery","volume":"25","author":"Kamonvarapitak","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"2021090119431005300_keab448-B32","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2021090119431005300_keab448-B33","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021090119431005300_keab448-B34","first-page":"477","article-title":"Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis","volume":"56","author":"Jourde-Chiche","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021090119431005300_keab448-B35","doi-asserted-by":"crossref","first-page":"e0196117","DOI":"10.1371\/journal.pone.0196117","article-title":"Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: clinical\/pathologic associations and etiologic mechanisms","volume":"13","author":"Wither","year":"2018","journal-title":"PLoS One"},{"key":"2021090119431005300_keab448-B36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MED.0000000000000485","article-title":"Neutrophils and type 1 diabetes: current knowledge and suggested future directions","volume":"26","author":"Battaglia","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2021090119431005300_keab448-B37","doi-asserted-by":"crossref","first-page":"19083","DOI":"10.1073\/pnas.1905054116","article-title":"Phenotypically distinct neutrophils patrol uninfected human and mouse lymph nodes","volume":"116","author":"Lok","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021090119431005300_keab448-B38","doi-asserted-by":"crossref","first-page":"e96492","DOI":"10.1172\/jci.insight.96492","article-title":"Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis","volume":"3","author":"Olaru","year":"2018","journal-title":"JCI Insight"},{"key":"2021090119431005300_keab448-B39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ajkd.2007.04.012","article-title":"Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis","volume":"50","author":"Yoshimoto","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"2021090119431005300_keab448-B40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"2021090119431005300_keab448-B41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.immuni.2016.04.014","article-title":"Mass cytometry of the human mucosal immune system identifies tissue- and disease-associated immune subsets","volume":"44","author":"van Unen","year":"2016","journal-title":"Immunity"},{"key":"2021090119431005300_keab448-B42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2018.10.046","article-title":"Single-cell RNA sequencing of blood and ileal T cells from patients with crohn's disease reveals tissue-specific characteristics and drug targets","volume":"156","author":"Uniken Venema","year":"2019","journal-title":"Gastroenterology"},{"key":"2021090119431005300_keab448-B43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"2021090119431005300_keab448-B44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"2021090119431005300_keab448-B45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021090119431005300_keab448-B46","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"key":"2021090119431005300_keab448-B47","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2021090119431005300_keab448-B48","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"2021090119431005300_keab448-B49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","article-title":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","volume":"397","author":"Humby","year":"2021","journal-title":"Lancet"},{"key":"2021090119431005300_keab448-B50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab448\/39309954\/keab448.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/3977\/40215008\/keab448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/9\/3977\/40215008\/keab448.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:44:19Z","timestamp":1630525459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/9\/3977\/6277904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5,18]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab448","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,5,18]]}}}